Strand Therapeutics

Strand originated from collaborative efforts of biological engineers at MIT, who aimed to innovate smart therapies through the application of mRNA therapeutics. The team established a new platform by developing a unique mRNA 'programming language' to enhance the safety and efficacy of therapeutic protein expression within the patient's body.